Results 331 to 340 of about 1,662,629 (361)
Some of the next articles are maybe not open access.

Efficacy of Topical Atorvastatin for the Treatment of Pressure Ulcers: A Randomized Clinical Trial

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
To evaluate the effects of topical atorvastatin on the healing process of pressure ulcers in critically ill patients.Randomized, double-blind, placebo-controlled clinical trial.Medical-surgical intensive care unit of a university-affiliated teaching hospital in Tehran, Iran.One hundred four patients with stage I or II pressure ulcers, graded according ...
Mohammad Taghi Beigmohammadi   +5 more
openaire   +3 more sources

Clinical Trials with Topical Vitamin A Acid

Southern Medical Journal, 1971
T L, Standlee, J P, Tindall
openaire   +2 more sources

Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III

open access: closed, 2021
Pierre Péterlin   +15 more
openalex   +2 more sources

Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: SELECT-MDS-1 TRIAL IN PROGRESS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TAMIBAROTENE/AZACITIDINE VS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED (ND) ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS

open access: closed, 2023
A. Dezern   +18 more
openalex   +1 more source

Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms

Journal of Cancer Research and Clinical Oncology, 2016
Ning Zhang   +5 more
semanticscholar   +1 more source

230 Feasibility study of targeted sequencing-based molecular prescreening of patients for Phase I clinical trials. Trial of Oncopanel for Introduction into Clinical Study Phase 1 (TOPICS-1)

open access: closed, 2015
Y. Tanabe   +8 more
openalex   +1 more source

Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: PEVAZ: A PHASE II STUDY OF PEVONEDISTAT AND AZACITIDINE IN MDS AND MDS/MPN PATIENTS RELAPSED OR REFRACTORY TO DNMT INHIBITION (DNMTI)

open access: closed, 2023
J. Watts   +20 more
openalex   +1 more source

Home - About - Disclaimer - Privacy